FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965172642> ?p ?o ?g. }

• W1965172642 abstract "The aim of this study was to evaluate the efficacy and the safety of bimatoprost in an outpatient glaucoma practice and to correlate the responsiveness to this treatment with the central corneal thickness.Our retrospective analysis included 55 consecutive patients (mean age, 66 years). Bimatoprost was administered in monotherapy in 32 patients and in combined treatment in 23. Mean follow-up was 5.5 months. In bilateral treatments (33/55 patients), only one eye (with the more severe defect and/or the higher IOP) was included in the analysis. The patients were considered as responders to bimatoprost when the observed reduction of IOP was > or = 20% and/or at least 3 mmHg compared with the pretreatment IOP. The mean central corneal thickness (CCT) was extrapolated from five consecutive measurements with the ultrasonic pachymeter Pachette.Overall, the mean IOP was reduced from a pretreatment value of 21.1 mmHg to 17.3 mmHg at the last visit (mean IOP decrease, 3.6 mmHg, or 17%) (p < 0.05). Except for four patients (7.3%) who discontinued bimatoprost secondary to local or systemic adverse effects, ocular tolerance of bimatoprost was excellent in 62%. Moderate conjunctival hyperemia was present in 18%. The mean IOP reduction was 19% in monotherapy and 15% in combined treatments. Concomitantly, the percentage of responders was slightly higher in patients only receiving bimatoprost than in patients receiving bimatoprost associated with other medication (s). In monotherapy, bimatoprost induced a further IOP decrease of 12% compared with a previous association of two medications that did not include a prostaglandin (10 patients). In the 20 patients in whom bimatoprost had replaced another prostaglandin, a further mean IOP reduction of 11% was observed. The frequency of distribution of the responders to bimatoprost was not correlated with CCT (chi2, p > 0.05).Considering the limits of this study, our results suggested that bimatoprost was effective and well tolerated in most patients. The decrease in IOP and responsiveness to treatment appeared to be slightly higher in monotherapy than in combined treatments, equivalent to a combination of two medications without prostaglandin and equivalent to or slightly higher than other prostaglandins. The degree of responsiveness did not seem to be correlated with CCT." @default.
• W1965172642 created "2016-06-24" @default.
• W1965172642 creator A5091005286 @default.
• W1965172642 date "2005-03-01" @default.
• W1965172642 modified "2023-09-26" @default.
• W1965172642 title "Expérience du bimatoprost dans le traitement de l’hypertension oculaire et du glaucome chronique" @default.
• W1965172642 cites W161657482 @default.
• W1965172642 cites W179785385 @default.
• W1965172642 cites W1907435754 @default.
• W1965172642 cites W1972354143 @default.
• W1965172642 cites W2029340053 @default.
• W1965172642 cites W2040322156 @default.
• W1965172642 cites W2060032838 @default.
• W1965172642 cites W2064230716 @default.
• W1965172642 cites W2105624158 @default.
• W1965172642 cites W2127722163 @default.
• W1965172642 cites W2138342502 @default.
• W1965172642 cites W2162920074 @default.
• W1965172642 cites W2165035978 @default.
• W1965172642 cites W2410923218 @default.
• W1965172642 cites W2745347670 @default.
• W1965172642 cites W3025522717 @default.
• W1965172642 doi "https://doi.org/10.1016/s0181-5512(05)81055-1" @default.
• W1965172642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15883493" @default.
• W1965172642 hasPublicationYear "2005" @default.
• W1965172642 type Work @default.
• W1965172642 sameAs 1965172642 @default.
• W1965172642 citedByCount "0" @default.
• W1965172642 crossrefType "journal-article" @default.
• W1965172642 hasAuthorship W1965172642A5091005286 @default.
• W1965172642 hasConcept C118487528 @default.
• W1965172642 hasConcept C2776521421 @default.
• W1965172642 hasConcept C2777336333 @default.
• W1965172642 hasConcept C2778527774 @default.
• W1965172642 hasConcept C2781092963 @default.
• W1965172642 hasConcept C71924100 @default.
• W1965172642 hasConceptScore W1965172642C118487528 @default.
• W1965172642 hasConceptScore W1965172642C2776521421 @default.
• W1965172642 hasConceptScore W1965172642C2777336333 @default.
• W1965172642 hasConceptScore W1965172642C2778527774 @default.
• W1965172642 hasConceptScore W1965172642C2781092963 @default.
• W1965172642 hasConceptScore W1965172642C71924100 @default.
• W1965172642 hasLocation W19651726421 @default.
• W1965172642 hasLocation W19651726422 @default.
• W1965172642 hasOpenAccess W1965172642 @default.
• W1965172642 hasPrimaryLocation W19651726421 @default.
• W1965172642 hasRelatedWork W1130188723 @default.
• W1965172642 hasRelatedWork W179785385 @default.
• W1965172642 hasRelatedWork W2004442119 @default.
• W1965172642 hasRelatedWork W2045012349 @default.
• W1965172642 hasRelatedWork W2058087195 @default.
• W1965172642 hasRelatedWork W2069899266 @default.
• W1965172642 hasRelatedWork W2162221629 @default.
• W1965172642 hasRelatedWork W2586227354 @default.
• W1965172642 hasRelatedWork W4288734821 @default.
• W1965172642 hasRelatedWork W2189452940 @default.
• W1965172642 isParatext "false" @default.
• W1965172642 isRetracted "false" @default.
• W1965172642 magId "1965172642" @default.
• W1965172642 workType "article" @default.